Skip to content

Abnormal cytology in dogs: medicines most often reported

1,746 FDA reports in dogs mention abnormal cytology. These are the medicines named most often in those reports.

Oclacitinib (Apoquel)

408 1.4% of its reports

Moxidectin (ProHeart 6)

234 0.5% of its reports

Bedinvetmab (Librela)

224 1.1% of its reports

Carprofen (Rimadyl)

221 0.5% of its reports

172 1.9% of its reports

Fluralaner (Bravecto)

154 0.2% of its reports

Lokivetmab (Cytopoint)

150 2.3% of its reports

149 1.7% of its reports

Melarsomine (Immiticide)

126 0.6% of its reports

Maropitant (Cerenia)

111 0.9% of its reports

105 1.1% of its reports

Leptospirosis Vaccine

97 1.2% of its reports

96 2.4% of its reports

Bordetella Vaccine

90 1.0% of its reports

Florfenicol + Mometasone + Terbinafine

88 2.5% of its reports

Amoxicillin + Clavulanate (Clavamox)

85 1.6% of its reports

Ivermectin + Pyrantel (Heartgard Plus)

73 0.0% of its reports

59 1.5% of its reports

Afoxolaner (NexGard)

58 0.1% of its reports

Enrofloxacin (Baytril)

57 1.5% of its reports

Diphenhydramine

52 1.1% of its reports

52 2.1% of its reports

51 2.3% of its reports

Grapiprant (Galliprant)

51 0.6% of its reports

Pyrantel + Sarolaner (Simparica Trio)

51 0.1% of its reports

46 1.7% of its reports

45 1.7% of its reports

Trilostane (Vetoryl)

44 0.4% of its reports

Distemper-parvo Vaccine

44 0.7% of its reports

43 1.0% of its reports

43 1.1% of its reports

Cefovecin (Convenia)

42 1.1% of its reports

Ilunocitinib (Zenrelia)

41 1.9% of its reports

40 1.3% of its reports

39 1.5% of its reports

Milbemycin Oxime + Praziquantel (Interceptor Plus)

37 0.1% of its reports

36 2.3% of its reports

35 1.2% of its reports

Cyclosporine (Atopica)

32 0.2% of its reports

Dexmedetomidine (Dexdomitor)

32 0.6% of its reports

31 1.1% of its reports

Milbemycin Oxime + Spinosad (Trifexis)

31 0.0% of its reports

Betamethasone + Florfenicol + Terbinafine

31 1.3% of its reports

30 2.5% of its reports

Deracoxib (Deramaxx)

30 0.3% of its reports

Meloxicam (Metacam)

30 0.4% of its reports

30 0.4% of its reports

29 2.7% of its reports

26 2.2% of its reports

Lotilaner (Credelio)

26 0.3% of its reports

Sarolaner (Simparica)

23 0.1% of its reports

Ivermectin (Heartgard)

22 0.2% of its reports

Polysulfated Glycosaminoglycan

21 0.4% of its reports

Chondroitin + Glucosamine

21 0.8% of its reports

Clotrimazole + Gentamicin + Mometasone

21 0.8% of its reports

Capromorelin (Entyce)

21 1.4% of its reports

20 0.7% of its reports

20 2.1% of its reports